Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butorphanol and Flurbiprofen Axetil for Remifentanil-Induced Hyperalgesia
NCT02043366Completed
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Feb 2014
- Primary completion
- Jun 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of butorphanol and flurbiprofen axetil in opioid-induced hyperalgesia (OIH) and postoperative pain (6 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: Mechanical Hyperalgesia Threshold on the Dominant Inner Forearm at 24 hours. Started Feb 2014; status: completed.
02
Drugs
butorphanolflurbiprofen axetil
03
Conditions
opioid-induced hyperalgesia (OIH)postoperative pain
Beyond the preview
Go deeper on NCT02043366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02043366.